Details concerning the Potassium Chloride combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, ...

The Food and Drug Administration approved Glenmark Pharamceuticals' potassium chloride tablets. The tablets, used to treat a potassium deficiency, are a generic version of K Dur tablets produced by ...

These measures will help in smooth running of business of pharma wholesalers and distributors, All India Organisation of Chemists and Druggists (AIOCD) said. (Reuters) Glenmark Pharmaceuticals has ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

AUBURN, Ala. & TAIPEI, Taiwan--(BUSINESS WIRE)--Vitruvias Therapeutics Inc., an Auburn, Alabama-based finished-dose generic drug development company, has agreed to license an approved Potassium ...

Hyderabad, Dec 21 (PTI): Aurobindo Pharma Ltd Friday said it has got the approval of the US Food and Drug Administration (USFDA) to make and market potassium chloride tablets of 600 mg and 750 mg for ...

"Glenmark Pharmaceuticals Inc, USA has been granted final approval by the US Food and Drug Administration (USFDA) for Potassium Chloride Extended Release Tablets USP, 10mEq (750 mg) and 20mEq (1500mg) ...

Utilizing the United States Pharmacopeia and National Formulary (USP-NF) monographs enables pharmaceutical labs and manufacturers to meet strict quality regulations regarding drugs and formulations.

New Delhi, Oct 22 () Drug firm Granules India on Thursday said it has received marketing approval from the US health regulator for Potassium Chloride extended release tablets, used for treatment of ...

The tablets, used to treat a potassium deficiency, are a generic version of K Dur tablets produced by Merck Sharp & Dohm, a subsidiary of Kenilworth, N.J.-based Merck. The K Dur tablets reported ...

Granules has received marketing approval from the US Food and Drug Administration (USFDA) for Potassium Chloride extended release tablets USP in the strengths of 10 mEq (750 mg) and 20 mEq (1500 mg), ...

NEW DELHI: Glenmark Pharmaceuticals has received final approval from the US health regulator for Potassium Chloride Extended Release Tablets, used in treating low levels of potassium in blood.